How to Best Manage Iron Deficiency Anemia in Your Practice

Clinicians worldwide frequently encounter iron deficiency anemia, a leading cause of global disability. Specifically, this condition causes severe fatigue, weakness, and impaired concentration. However, many physicians overlook the diagnosis in menstruating women. This happens because standard hemoglobin reference ranges often fail to account for sex-specific variations. Consequently, patients suffer from persistent symptoms without receiving proper care.

Understanding Iron Deficiency Anemia

To establish a secure diagnosis, doctors must evaluate both ferritin and transferrin saturation. Although hemoglobin thresholds define anemia, iron deficiency can occur without low hemoglobin. Indeed, non-anemic iron deficiency also triggers significant clinical symptoms. For this reason, physicians should not rely solely on anemia markers. Instead, they must proactively screen high-risk groups like pregnant or menstruating individuals.

Evaluating the Underlying Causes

When diagnosing a patient, clinicians must investigate the underlying cause of the deficiency. First, they should perform a detailed gynecologic history for reproductive-age women. Next, standard diagnostic pathways require testing for celiac disease and Helicobacter pylori infection. Specifically, H. pylori impairs iron absorption by altering gastric pH levels. Therefore, treating this gastric infection directly improves the efficacy of subsequent oral iron supplementation.

In addition, adult patients often require a bidirectional endoscopy. This procedure helps exclude occult gastrointestinal bleeding from ulcers or malignancies. However, young, healthy women with obvious menstrual blood loss might bypass this invasive step initially. In these cases, clinicians may safely administer a therapeutic trial of oral iron. If the patient fails to respond, further gastrointestinal work-up becomes necessary.

Optimizing Treatment Approaches

The 2025 Iron Consortium Guideline outlines essential recommendations for repletion. Although oral iron represents the traditional first-line therapy, gastrointestinal side effects often limit compliance. To solve this issue, the consortium recommends alternate-day oral dosing. Furthermore, clinical trials show that alternate-day administration reduces side effects without compromising overall iron absorption. Consequently, patients tolerate the treatment much better.

Alternatively, clinicians should consider intravenous (IV) iron for patients who cannot tolerate oral forms. Additionally, IV iron provides a rapid cure for severe anemia or during late pregnancy. Some guidelines differ in their specific thresholds for IV administration. Nevertheless, experts agree that severe symptoms or poor oral absorption justify intravenous therapy. Therefore, matching the route of administration to individual patient needs ensures optimal outcomes.

Frequently Asked Questions

Q1: What are the primary diagnostic indicators for iron deficiency anemia?

A diagnosis requires both a confirmed state of anemia and evidence of depleted iron stores. Specifically, clinicians look for low serum ferritin levels and reduced transferrin saturation. However, they must remember that iron deficiency can also occur in the absence of clinical anemia.

Q2: Why does the 2025 Iron Consortium Guideline suggest alternate-day oral iron dosing?

Many patients report poor tolerance to daily oral iron due to gastrointestinal side effects. To address this, clinical evidence suggests that alternate-day dosing improves compliance. Moreover, this scheduling reduces unwanted side effects while maintaining excellent absorption rates. Consequently, it has become a preferred treatment option.

Q3: How does Helicobacter pylori infection relate to iron deficiency?

Chronic infection with Helicobacter pylori alters the gastric microenvironment and increases pH. As a result, this process impairs the absorption of dietary non-heme iron. Therefore, clinicians must test for this infection in unexplained or refractory cases. Eradication of the bacteria subsequently restores normal gastric function and enhances iron levels.

References

1. Cool JA et al. How Would You Manage This Patient With Iron Deficiency Anemia? Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med. 2026 Jun 09. doi: 10.7326/ANNALS-26-01369. PMID: 42258829.
2. Benson AE, Lo JO, Achebe MO, et al.; Iron Consortium at Oregon Health & Science University. Management of iron deficiency in children, adults, and pregnant individuals: evidence-based and expert consensus recommendations. Lancet Haematol. 2025 May;12(5):e376-e388. doi: 10.1016/S2352-3026(25)00038-9. PMID: 40306833.